GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Icon PLC (NAS:ICLR) » Definitions » Investments And Advances

Icon (ICLR) Investments And Advances : $51 Mil (As of Mar. 2024)


View and export this data going back to 1998. Start your Free Trial

What is Icon Investments And Advances?

Icon's Investments And Advances for the quarter that ended in Mar. 2024 was $51 Mil.

Icon's quarterly Investments And Advances increased from Sep. 2023 ($42 Mil) to Dec. 2023 ($47 Mil) and increased from Dec. 2023 ($47 Mil) to Mar. 2024 ($51 Mil).

Icon's annual Investments And Advances increased from Dec. 2021 ($25 Mil) to Dec. 2022 ($33 Mil) and increased from Dec. 2022 ($33 Mil) to Dec. 2023 ($47 Mil).


Icon Investments And Advances Historical Data

The historical data trend for Icon's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Icon Investments And Advances Chart

Icon Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.05 20.30 24.97 32.63 46.80

Icon Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 32.05 35.30 41.79 46.80 51.16

Icon Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Icon (ICLR) Business Description

Traded in Other Exchanges
Address
South County Business Park, Leopardstown, Dublin, IRL, D18 X5R3
Icon is a global late-stage contract research organization that provides drug development and clinical trial services to pharmaceutical, biotechnology, and medical device firms. While the vast majority of its revenue comes from clinical research, Icon also offers ancillary services such as laboratory and imaging capabilities. The company is headquartered in Ireland.